 , Analgesics , Analgesics, Non-Narcotic , Anticonvulsants , Antimanic Agents , Carboxamide Derivatives , Cardiovascular Agents , Central Nervous System Agents , Central Nervous System Depressants , Cytochrome P-450 CYP1A2 Inducers , Cytochrome P-450 CYP1A2 Inducers (strong) , Cytochrome P-450 CYP1A2 Inhibitors , Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) , Cytochrome P-450 CYP1A2 Substrates , Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2B6 Inducers , Cytochrome P-450 CYP2B6 Inducers (strong) , Cytochrome P-450 CYP2B6 Substrates , Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C19 Inducers , Cytochrome P-450 CYP2C19 Inducers (moderate) , Cytochrome P-450 CYP2C19 Inhibitors , Cytochrome P-450 CYP2C19 inhibitors (strength unknown) , Cytochrome P-450 CYP2C8 Inducers , Cytochrome P-450 CYP2C8 Inducers (strength unknown) , Cytochrome P-450 CYP2C8 Substrates , Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C9 Inducers , Cytochrome P-450 CYP2C9 Inducers (strength unknown) , Cytochrome P-450 CYP3A Inducers , Cytochrome P-450 CYP3A Inducers (strong) , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inducers , Cytochrome P-450 CYP3A4 Inducers (strong) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A5 Inducers , Cytochrome P-450 CYP3A5 Inducers (strength unknown) , Cytochrome P-450 CYP3A5 Inducers (strong) , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Decreased Central Nervous System Disorganized Electrical Activity , Dibenzazepines , Drugs that are Mainly Renally Excreted , Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index , Enzyme Inducing Antiepileptic Drugs , Heterocyclic Compounds, Fused-Ring , Immunosuppressive Agents , Inducers of Drug Clearance , Membrane Transport Modulators , Miscellaneous Anticonvulsants , Mood Stabilizer , Myelosuppressive Agents , Narrow Therapeutic Index Drugs , P-glycoprotein inducers , P-glycoprotein substrates , Peripheral Nervous System Agents , Psychotropic Drugs , Sensory System Agents , Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome , Sodium Channel Blockers , Thyroxine-binding globulin substrates , UGT1A1 Inducers , UGT1A6 inducer , UGT2B7 substrates , UGT2B7 Substrates with a Narrow Therapeutic Index